It can be challenging to gauge the quality of online news - questioning if it is real or if it is fake. When it comes to health news and press releases about medical treatments and procedures the issue can be even more complex, especially if the story is not complete and still doesn’t necessarily fall into the category of fake news.

Score another one for artificial intelligence. In a recent study, 151 human participants were pitted against ChatGPT-4 in three tests designed to measure divergent thinking, which is considered to be an indicator of creative thought.

Divergent thinking is characterized by the ability to generate a unique solution to a question that does not have one expected solution, such as "What is the best way to avoid talking about politics with my parents?"

Artificial intelligence (AI) helped clinicians to accelerate the design of diabetes prevention software, a new study finds.

Publishing online March 6 in the Journal of Medical Internet Research, the study examined the capabilities of a form of artificial intelligence called generative AI or GenAI, which predicts likely options for the next word in any sentence based on how billions of people used words in context on the internet.

Clinicians in Scotland have easy access to clinical guidelines and validated decision support tools using the Right Decision Service (RDS), built on technology developed by Tactuum.

The RDS is a once-for-Scotland national project funded by the Scottish Government and run by Healthcare Improvement Scotland.

Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.

A Cancer Research UK-funded study reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different subtypes termed evotypes.

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year - nearly a third of all health care spending - on treating preventable diseases like diabetes.

For the 98 million adults who are prediabetic and at risk of developing Type II diabetes, preventive treatments such as the drug metformin can help stave off the disease.